Masteron (Drostanolone)

Masteron (Drostanolone) is a DHT-derived anabolic steroid originally developed as a breast cancer treatment due to its potent anti-estrogenic properties. In the longevity and wellness space, it has gained attention as an adjunct to TRT protocols for its unique combination of mild anabolic effects, anti-estrogenic activity, and positive effects on mood and well-being. Drostanolone acts as a mild aromatase inhibitor, helping to manage estrogen levels without the joint pain, lipid disruption, and bone density concerns associated with pharmaceutical aromatase inhibitors like anastrozole. Many men on TRT who struggle with elevated estrogen find that adding low-dose Masteron provides estrogen management while simultaneously improving body composition, mood, and libido. As a DHT derivative, Masteron does not convert to estrogen and actually competes with estrogen at receptor sites. It promotes a lean, dry physique and is valued for its positive effects on mental well-being — many users report improved confidence, drive, and overall mood.